Sales rise 73.86% to Rs 4.59 crore
Net profit of Beryl Drugs declined 42.22% to Rs 0.26 crore in the quarter ended June 2012 as against Rs 0.45 crore during the previous quarter ended June 2011. Sales rose 73.86% to Rs 4.59 crore in the quarter ended June 2012 as against Rs 2.64 crore during the previous quarter ended June 2011. ParticularsQuarter EndedJun. 2012Jun. 2011% Var.Sales4.592.64 74 OPM %7.8423.11 -66 PBDT0.350.59 -41 PBT0.270.51 -47 NP0.260.45 -42Powered by Capital Market - Live News